Takeaway
- Esmolol hydrochloride 14% topical gel, a novel therapy option, treated diabetic foot ulcers (DFU) much better than the standard of care (SoC) and did not cause any significant drug-related safety issues.
Esmolol hydrochloride is an intravenously administered β-1-selective (cardioselective) adrenergic receptor blocking agent that has been approved for the...